
Peter Van Loo, Ph.D.
Department of Genetics, Division of Discovery Science
About Dr. Peter Van Loo
Dr. Van Loo is a Professor and CPRIT scholar at the University of Texas MD Anderson Cancer Center, Department of Genetics, with a joint appointment at the Department of Genomic Medicine. His research focuses on leveraging massively parallel sequencing efforts to study the evolutionary history of cancers. During his postdoctoral training, Dr. Van Loo developed computational techniques to study copy-number alterations in cancer genomes, and approaches to study the evolutionary history and subclonal architecture of tumors from whole-genome sequencing data, a field coined molecular archeology of cancer. As an independent researcher, first as a Group Leader at the Francis Crick Institute in London, UK, and later as a Professor at the University of Texas MD Anderson Cancer Center, Dr. Van Loo has sketched the typical evolutionary trajectories of many cancer types, allowing insight into the timelines of cancer development, as well as insight into how tumors metastasize. He was the main lead of Evolution and Heterogeneity working group of the Pan-Cancer Analysis of Whole Genomics (PCAWG) Consortium, and am the genomics lead of the Sarcoma arm of the 100,000 Genomes Project.
In recognition of his work, Dr. Van Loo has been awarded a Cancer Research UK Future Leaders in Cancer Research Prize in 2015, a VIB Alumni Award in 2017, and a UT STARs award in 2022. He co-authored 141 publications in international journals, including Nature (15), Science (5), Cell (7), New England Journal of Medicine (3), Cancer Discovery (1), Nature Genetics (12), Cancer Cell (5), Nature Medicine (2) and Nature Biotechnology (7). These have accumulated 35,095 citations (H-index: 68).
View a complete list of Dr. Van Loo's publications. Visit Dr. Van Loo’s Lab website. Follow Dr. Van Loo on Twitter: @VanLooLab View Dr. Van Loo’s publication highlights as reflected in Elsevier’s Scopus database.
Present Title & Affiliation
Primary Appointment
Professor, Department of Genetics, Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Visiting Group Leader, The Francis Crick Institute, London
Dual/Joint/Adjunct Appointment
Professor, Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Visiting Group Leader, The Francis Crick Institute, London
Research Interests
Cancer Genomics and Evolution – Molecular archeology of cancer
Our group has pioneered molecular archeology of cancer approaches to study the evolutionary history and subclonal architecture of tumors. These approaches have significantly advanced our understanding of how cancer develops and evolves, how metastatic cancer spreads, and how resistance to therapy emerges. We use these existing molecular archeology of cancer approaches and develop novel ones, to perform large-scale pan-cancer studies of tumor evolution, as well as focused studies in specific tumor types, aiming to answer the key question: How do tumors evolve?
View a complete list of Dr. Van Loo's publications. Visit Dr. Van Loo’s Lab website. Follow Dr. Van Loo on Twitter: @VanLooLab View Dr. Van Loo’s publication highlights as reflected in Elsevier’s Scopus database.
Education & Training
Degree-Granting Education
2008 | University of Leuven, Leuven, BE, Medical Sciences, Ph.D |
2004 | University of Leuven, Leuven, BE, Cell- and Gene Biotechnology, M.S |
2003 | University of Leuven, Leuven, BE, Electrotechnical Engineering, M.S |
Postgraduate Training
2010-2014 | Postdoctoral Researcher, Wellcome Trust Sanger Institute, Hinxton, Cambridge |
2008-2010 | Postdoctoral Researcher, VIB and University of Leuven, Leuven |
2008-2008 | Postdoctoral Researcher, University of Oslo, Oslo |
Experience & Service
Faculty Academic Appointments
Group Leader, The Francis Crick Institute, London, 2014 - 2021
Assistant Professor (10% appointment), University of Leuven, Leuven, 2013 - 2019
Intramural Institutional Committee Activities
member, Data Science Faculty Recruitment Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
co-chair, Research Storage Planning and Governance Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
member, Physician Scientist Program Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
co-chair, Mike Hogg Award/Lecture Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
member, Research Storage Planning and Governance Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
co-organizer, Department of Genetics Research Exchange Seminar Series, The University of Texas MD Anderson Cancer Center, 2022 - 2024
member, Mike Hogg Award/Lecture Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
member, Advanced Technology Genomics Core (ATGC) Oversight Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Extramural Institutional Committee Activities
member, Newton Prize Committee, British Council, 2020
member, Research Degrees Committee, The Francis Crick Institute, 2019 - 2021
member, Scientific Computing User Group, The Francis Crick Institute, 2018 - 2021
member, Crick Group Leader Search Committee, The Francis Crick Institute, 2016 - 2022
Editorial Activities
Advisory Editor, Cancer Research special series: driving cancer discoveries with computational research, data science and machine learning/AI, 2024 - Present
Editorial Board Member, NAR Cancer, 2019 - Present
Honors & Awards
2025 | Research Excellence Award, The University of Texas MD Anderson Cancer Center |
2022 | UT STARs Award |
2017 | VIB Alumni Award |
2015 | Cancer Research UK Future Leaders in Cancer Research Prize |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Molecular archeology of cancer. Invited. Minneapolis, Minnesota, US.
- 2025. Reconstructing cancer's evolutionary history. Invited. Data Science Forum. Houston, Texas, US.
- 2025. Molecular archeology of cancer. Invited. Leuven, BE.
- 2024. Molecular archeology of cancer. Invited. Gallick Meeting. Houston, Texas, US.
- 2024. Molecular archeology of cancer. Invited. MCO Distinguished Scientist Seminar Series. Houston, Texas, US.
- 2024. Molecular archeology of cancer. Invited. Portland, Oregon, US.
- 2024. Molecular archeology of cancer. Invited. Frontiers in Genomics. Cuernavaca, MX.
- 2024. Reconstructing cancer’s evolutionary history. Invited. Frontiers in Genomics. Cuernavaca, MX.
- 2023. Molecular archeology of cancer. Invited. Houston, TX, US.
- 2023. Molecular archeology of cancer. Invited. Brain Tumor Center Scientific Retreat. Houston, TX, US.
- 2023. Molecular archeology of cancer. Invited. Chapel Hill, NC, US.
- 2022. Reconstructing cancer's evolutionary history. Invited. Blaffer Lecture. Houston, TX, US.
- 2022. Molecular archeology of cancer. Invited. Singapore, SG.
- 2022. Molecular archeology of cancer. Invited. Seattle, WA, US.
- 2022. Molecular archeology of cancer. Invited. Paris, FR.
- 2021. Molecular archaeology of cancer. Invited. Norwich, GB.
- 2020. Molecular archeology of cancer. Invited. New York, NY, US.
- 2020. Molecular archaeology of cancer. Invited. Leuven, BE.
- 2019. Molecular archeology of cancer. Invited. New York, NY, US.
- 2019. Molecular archaeology of cancer. Invited. Sutton, GB.
- 2019. Molecular archaeology of cancer. Invited. Oxford, GB.
- 2019. Molecular archaeology of cancer. Invited. Southampton, GB.
- 2018. The genetic archaeology of 2,658 cancers. Invited. Boston, MA, US.
- 2018. Molecular archaeology of cancer. Invited. Berlin, DE.
- 2018. Molecular archaeology of cancer. Invited. Houston, TX, US.
- 2017. Molecular archaeology of cancer. Invited. Tampere, FI.
- 2017. Molecular archaeology of cancer. Invited. London, GB.
- 2017. Molecular archaeology of cancer. Invited. Manchester, GB.
- 2016. Molecular archaeology of cancer. Invited. London, GB.
- 2016. Molecular archaeology of cancer. Invited. Aarhus, DK.
- 2015. Molecular archaeology of breast cancer. Invited. Toronto, CA.
- 2015. Molecular archaeology of cancer. Invited. Oxford, GB.
- 2015. Molecular archaeology of cancer. Invited. Colchester, GB.
- 2014. Genomic ventures to identify cancer genes and explore intra-tumour heterogeneity. Invited. Lecture Visiting Professorship Programme. Krakow, PL.
- 2012. The life history of 21 breast cancers. Invited. Cambridge, GB.
- 2012. The life history of 21 breast cancers. Invited. Princeton, NJ, US.
- 2012. The life histories of 21 breast cancers. Invited. Chicago, IL, US.
- 2011. Allele-specific copy number analysis of breast carcinomas. Invited. Beerse, BE.
- 2007. Gene prioritization by genomic data fusion. Invited. Maastricht, NL.
National Presentations
- 2024. Molecular archeology of cancer. Invited. Gordon Research Conference Single-Cell Cancer Biology: Deciphering Tumor Ecosystems in Space and Time. Manchester, NH, US.
- 2024. Molecular archeology of cancer. Invited. AACR Special Conference on DNA Damage Repair: From Basic Science to Future Clinical Application. Washington, DC, US.
- 2023. Molecular archeology of cancer (keynote presentation). Invited. AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier. Boston, MA, US.
- 2023. Molecular archeology of cancer. Invited. The Biology of Genomes. Cold Spring Harbor, NY, US.
- 2023. Molecular archeology of cancer. Invited. NCI Spring School on Algorithmic Cancer Biology (SSACB). Bethesda, MD, US.
- 2020. Molecular archeology of cancer. Invited. California Precision Health Summit. Los Angeles, CA, US.
- 2019. The evolutionary history of 2,658 cancers. Conference. American Society of Human Genetics 2019 Annual Meeting. Houston, TX, US.
- 2017. The genetic archaeology of 2,703 cancers. Invited. American Association for Cancer Research (AACR) annual meeting 2017. Washington, DC, US.
- 2016. Tracing the origin of disseminated tumour cells in breast cancer using single cell sequencing. Invited. Mathematical Biosciences Institute workshop on Oncogenesis, Clonality, and Tumor Progression. Columbus, OH, US.
- 2016. Molecular archaeology of cancer. Invited. Breast Cancer Metastasis & Recurrence: Prevention, Detection and Immunotherapies. Philadelphia, PA, US.
- 2015. Bulk sequencing and single cell approaches for molecular archaeology of cancer. Invited. American Association for Cancer Research (AACR) annual meeting 2015. Philadelphia, PA, US.
- 2013. The landscape of tumor suppressors in primary tumors. Conference. The American Society of Human Genetics (ASHG) 63th Annual Meeting. Boston, MA, US.
- 2009. Elucidation of tumor aneuploidy, non-aberrant cell infiltration and LOH from genome wide SNP data in breast carcinoma. Conference. The American Society of Human Genetics (ASHG) 59th Annual Meeting. Honolulu, HI, US.
International Presentations
- 2025. Molecular archeology of cancer. Invited. The Mark Foundation Workshop on Chromosomal Instability in Cancer. New Haven, US.
- 2025. Molecular archeology of cancer. Invited. RECOMB - Computational Cancer Biology. Seoul, KR.
- 2024. Molecular archeology of cancer. Invited. Princess Margaret Cancer Center – MD Anderson Cancer Center Slaight Breakthrough Symposium. Toronto, CA.
- 2023. Molecular archeology of cancer. Invited. Breast cancer Theme Center Symposium: Intra-tumor heterogeneity (virtual). Stockholm, SE.
- 2023. Adventures in copy number analysis, subclonal reconstruction and deconvolution. Invited. BIRS (Banff International Research Station for Mathematical Innovation and Discovery) workshop: Mathematical methods in cancer biology, evolution and therapy. Banff, CA.
- 2022. Molecular archeology of cancer. Invited. 43rd Frontier Scientists Workshop on behalf of the Korean Academy of Science. San Diego, US.
- 2022. Molecular archeology of cancer. Invited. Bienniel Congress of the Metastasis Research Society. Buenos Aires, AR.
- 2022. Molecular archeology of cancer. Invited. Nature Publishing Group Ecology & Evolution and Cancer Community (virtual). London, GB.
- 2022. Molecular archeology of cancer. Invited. WE-Heraeus-Seminar: Evolution of Cancer – Reconstructing the Past, Predicting the Future. Bad Honnef, DE.
- 2022. Molecular archeology of cancer. Invited. The 2nd International Electronic Conference on Cancers – Tumor Microenvironment Heterogeneity in Cancer Progression: Challenge or Opportunity (virtual), US.
- 2020. Molecular archeology of cancer. Invited. Association for Molecular Pathology Annual Meeting (virtual), US.
- 2020. Molecular archaeology of cancer. Invited. Advanced Personalized Therapeutics in Gynecological Cancers. Oxford, GB.
- 2019. Molecular archaeology of cancer. Invited. Otto Warburg International Summer School and Research Symposium on Cell-Type Heterogeneity and Single-Cell Analysis. Shanghai, CN.
- 2019. Inferring intra-tumour heterogeneity and tumour evolution using bulk and single-cell sequencing. Invited. Otto Warburg International Summer School and Research Symposium on Cell-Type Heterogeneity and Single-Cell Analysis. Shanghai, CN.
- 2019. Molecular archaeology of cancer. Invited. Towards in silico-guided clinical trials in cancer workshop. Oslo, NO.
- 2019. Molecular archaeology of cancer. Invited. Single-cell and Massively Parallel Approaches Workshop. Holetown, BB.
- 2018. Punctuated evolution in cancer genomes. Invited. NCRI Cancer Conference. Glasgow, GB.
- 2018. Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types. Invited. 14th International Cancer Genome Consortium (ICGC) / 1st ICGC-Accelerating Research in Genomic Oncology (ARGO) Scientific Workshop. Paris, FR.
- 2018. The genetic archaeology of 2,658 cancers. Invited. Pan-Cancer Analysis of Whole Genomes Symposium. Toronto, CA.
- 2018. Molecular archaeology of cancer: perspectives for application to cancer of unknown primary. Invited. NCRI and NIHR Research in Acute Oncology and Cancer of Unknown Primary Workshop. London, GB.
- 2017. Molecular archaeology of cancer. Invited. Shanghai Cancer Center. Shanghai, CN.
- 2017. Molecular archaeology of cancer. Invited. Challenges and Synergies in the Analysis of Large-Scale Population-Based Biomedical Data. Oaxaca, MX.
- 2017. The evolutionary history of 2,658 cancers. Conference. EMBL Cancer Genomics. Heidelberg, DE.
- 2017. Molecular archaeology of cancer. Invited. Bertinoro Computational Biology meeting. Bertinoro, IT.
- 2017. The genetic archaeology of 2,778 cancers. Invited. 13th International Cancer Genome Consortium (ICGC) scientific workshop. Seoul.
- 2017. Genetic archaeology of cancer dissemination. Invited. CRUK Marshall Symposium on Cancer Evolution. Sussex, GB.
- 2017. Molecular archaeology of cancer, Keynote Speaker. Invited. Visions In Pharmacology. Toronto, CA.
- 2016. Molecular archaeology of cancer. Invited. 9th International Conference of the ERCIM WG on Computational and Methodological Statistics (CMStatistics 2016). Sevilla, ES.
- 2016. Molecular archaeology of cancer. Invited. Asia-Pacific Prostate Cancer Conference 2016. Melbourne, AU.
- 2016. The genetic archaeology of 2,778 cancers. Invited. 12th International Cancer Genome Consortium (ICGC) scientific workshop. Boston, US.
- 2016. Tracing the origin of disseminated tumour cells in breast cancer using single cell sequencing. Invited. Asia-Pacific Prostate Cancer Conference 2016. Melbourne, AU.
- 2016. Molecular archaeology of cancer. Invited. CRUK All Fellows meeting. York, GB.
- 2016. Molecular archaeology of cancer. Invited. Personalized Cancer Care. Oslo, NO.
- 2016. Evolution and Heterogeneity. Invited. PCAWG network meeting. Barcelona, ES.
- 2016. Molecular archaeology of cancer. Invited. Joint meeting of the Belgian Society of Human Genetics and the Netherlands Society for Human Genetics. Leuven, BE.
- 2016. Molecular archaeology of cancer. Invited. Festival of Genomics. London, GB.
- 2015. Molecular archaeology of cancer. Invited. NCRI Cancer Conference. Liverpool, GB.
- 2015. Molecular archaeology of cancer. Invited. Bringing Maths to Life (BMTL) workshop. Naples, IT.
- 2015. Molecular archaeology of cancer, Keynote Presentation. Invited. Cancer Research UK Bioinformatics Summer School: Best practices in the analysis of RNA-Seq and ChIP-Seq data. Cambridge, GB.
- 2015. Molecular archaeology of cancer by bulk and single cell sequencing. Invited. BACR/CRUK Evolution and Intratumoural Heterogeneity Meeting. London, GB.
- 2015. Genomic ventures to explore tumour development and intra-tumour heterogeneity in breast cancer. Invited. IMPAKT 2015 Breast Cancer Conference. Brussels, BE.
- 2015. Molecular archaeology of cancer. Invited. Revolutionizing next-generation sequencing: tools and technologies. Leuven, BE.
- 2014. Genomic ventures to identify cancer genes and explore intra-tumour heterogeneity. Invited. 5th Roger Monier meeting. Paris, FR.
- 2013. The landscape of tumor suppressors in primary tumors. Conference. EMBL Conference “Cancer Genomics”. Heidelberg, DE.
- 2013. The landscape of tumour suppressors across primary tumours, presentation in presidential session (audience: ~2,500). Conference. The European Cancer Congress (ECC 2013). Amsterdam, NL.
- 2013. Copy number meta-analysis across primary tumours highlights distinct genomic architecture and identifies tumour suppressors. Conference. EACR summer conference on Cancer Genomics. Cambridge, GB.
- 2013. Genomic ventures into inter- and intra-tumour heterogeneity of breast cancer. Invited. Fifth Annual European Network of Breast Development and Cancer labs (ENBDC) workshop: Methods in mammary gland biology and breast cancer. Weggis, CH.
- 2013. Studying intra-tumour heterogeneity by massively parallel sequencing. Invited. EMBL-EBI Industry Programme workshop on Oncogenomics. Cambridge, GB.
- 2013. Studying intra-tumor heterogeneity by massively parallel sequencing: mechanisms and clinical implications, Keynote Presentation. Invited. Fourth International Symposium on Adrenal Cancer. Paris, FR.
- 2012. The life history of 21 breast cancers. Conference. 11th European Conference on Computational Biology (ECCB 2012). Basel, CH.
- 2012. The life history of 21 breast cancers. Conference. Personalized Cancer Care Symposium. Oslo, NO.
- 2012. The life history of 21 breast cancers. Conference. 22nd Biennial Congress of the European Association for Cancer Research (EACR 2012). Barcelona, ES.
- 2010. Allele-specific copy number analysis of breast carcinomas. Conference. 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB 2010). Boston, US.
- 2010. Allele-specific copy number analysis of breast carcinomas. Conference. Second Annual RECOMB Satellite Workshop on Computational Cancer Biology. Oslo, NO.
- 2006. Gene prioritization by genomic data fusion. Conference. 14th International Conference on Intelligent Systems for Molecular Biology (ISMB 2006), Student Council Symposium. Fortaleza, BR.
- 2005. Computational identification of cis-regulatory modules in mammalian genomes and the evolutionary conservation of transcription factor binding sites. Conference. Otto Warburg International Summer School and Workshop on Networks and Regulation. Berlin, DE.
Grant & Contract Support
Date: | 2025 - 2030 |
Title: | Computational Approaches to Reconstruct the Evolutionary History of Cancer Metastases, Impact Score 22, Percentile: 1 |
Funding Source: | NCI |
Role: | PI |
ID: | 1R01CA299449-01A1 |
Date: | 2024 - 2025 |
Title: | Next-generation signatures of mutational processes shaping chromosomal instability in cancer |
Funding Source: | Mark Foundation |
Role: | Co-I |
Date: | 2023 - 2026 |
Title: | APOBEC3A drives tumor evolution and intra-tumor heterogeneity in PDAC |
Funding Source: | Department of Defense (DOD) |
Role: | PI |
Date: | 2021 - 2026 |
Title: | Recruitment of Established Investigators - Dr. Peter Van Loo |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | PI |
ID: | RR210006 |
Date: | 2021 - 2024 |
Title: | Characterizing the somatic genomic landscape of malignant peripheral nerve sheath tumours at single-cell and single-molecule resolution |
Funding Source: | NF Research Initiative |
Role: | PI |
Date: | 2019 - 2022 |
Title: | GeCIPing Sarcoma: A UK-led initiative to personalize sarcoma treatment |
Funding Source: | Project funding Sarcoma UK |
Role: | Co-PI |
Date: | 2017 - 2019 |
Title: | Single-cell multi-omics approach to study intra-tumour heterogeneity of soft tissue sarcomas (SIOMICS) |
Funding Source: | Marie Curie postdoc fellowship |
Role: | Supervisor |
Date: | 2016 - 2018 |
Title: | Allele-specific deconvolution of tumour DNA methylation and expression data to reveal underlying cell populations (DECODE) |
Funding Source: | Marie Curie postdoc fellowship |
Role: | Supervisor |
Date: | 2015 - 2017 |
Title: | Single-cell and fine-needle biopsy DNA- and RNA-sequencing to dissect the emergence, biology and therapeutic resistance of cancer cell lineages |
Funding Source: | Foundation Against Cancer (Belgium) |
Role: | PI |
Date: | 2014 - 2021 |
Title: | Cancer Genomics |
Funding Source: | Cancer Research UK, Medical Research Council and Wellcome Trust |
Role: | PI |
ID: | CC2008 |
Selected Publications
Peer-Reviewed Articles
- Tang C, Sherry AD, Seo A, Hara K, Choi H, Liu S, Sun X, Montoya A, Ludmir EB, Shah AY, Jonasch E, Zurita AJ, Kovitz C, Alhalabi O, Goswami S, Hahn AW, Campbell MT, Hernandez A, Nead KT, Van Loo P, Su S, Battey CJ, LaBella ML, Ratzel S, Acevedo A, Genovese G, Sircar K, Karam JA, Tannir NM, Msaouel P. Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial. Lancet Oncol, 2025. e-Pub 2025. PMID: 40915303.
- Gimeno-Valiente F, Castignani C, Larose Cadieux E, Mensah NE, Liu X, Chen K, Chervova O, Karasaki T, Weeden CE, Richard C, Lai S, Martinez-Ruiz C, Lim EL, Frankell AM, Watkins TBK, Stavrou G, Usaite I, Lu WT, Marinelli D, Saghafinia S, Wilson GA, Dhami P, Vaikkinen H, Steif J, Veeriah S, Hynds RE, Hirst M, Hiley C, Feber A, Deniz O, Jamal-Hanjani M, McGranahan N, Beck S, Demeulemeester J, Tanic M, Swanton C, Van Loo P, Kanu N. DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolution. Nat Genet 57(9):2226-2237, 2025. e-Pub 2025. PMID: 40931149.
- Salcedo A, Tarabichi M, Buchanan A, Espiritu SMG, Zhang H, Zhu K, Ou Yang TH, Leshchiner I, Anastassiou D, Guan Y, Jang GH, Mootor MFE, Haase K, Deshwar AG, Zou W, Umar I, Dentro S, Wintersinger JA, Chiotti K, Demeulemeester J, Jolly C, Sycza L, Ko M, Wedge DC, Morris QD, Ellrott K, Van Loo P, Boutros PC. Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction. Nat Biotechnol 43(4):581-592, 2025. e-Pub 2025. PMID: 38862616.
- Bentham, R, Jones, TP, Black, JR, Martínez-Ruiz, C, Dietzen, M, Litovchenko, M, Thol, K, Watkins, TB, Bailey, C, Pich, O, Zhang, Z, Van Loo, P, Swanton, C, McGranahan, N. ImmuneLENS characterizes systemic immune dysregulation in aging and cancer. Nature Genetics 57(3):694-705, 2025. e-Pub 2025. PMID: 39966644.
- Baker TM, Lai S, Lynch AR, Lesluyes T, Yan H, Ogilvie HA, Verfaillie A, Dentro S, Bowes AL, Pillay N, Flanagan AM, Swanton C, Spellman PT, Tarabichi M, Van Loo P. The History of Chromosomal Instability in Genome-Doubled Tumors. Cancer Discov 14(10):1810-1822, 2024. e-Pub 2024. PMID: 38943574.
- Puttick C, Jones TP, Leung MM, Galvez-Cancino F, Liu J, Varas-Godoy M, Rowan A, Pich O, Martinez-Ruiz C, Bentham R, Dijkstra KK, Black JRM, Rosenthal R, Kanu N, Litchfield K, Salgado R, Moore DA, Van Loo P, Jamal-Hanjani M, Quezada SA, Swanton C, McGranahan N. MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nat Genet 56(10):2121-2131, 2024. e-Pub 2024. PMID: 39358601.
- John E, Lesluyes T, Baker TM, Tarabichi M, Gillenwater A, Wang JR, Van Loo P, Zhao X. Reconstructing oral cavity tumor evolution through brush biopsy. Sci Rep 14(1):22591, 2024. e-Pub 2024. PMID: 39343812.
- Rahman S, Bloye G, Farah N, Demeulemeester J, Costa JR, O'Connor D, Pocock R, Rapoz-D'Silva T, Turna A, Wang L, Lee SW, Fielding AK, Roels J, Jaksik R, Dawidowska M, Van Vlierberghe P, Hadjur S, Hughes JR, Davies J, Gutierrez A, Kelliher M, Van Loo P, Dawson MA, Mansour MR. Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia. Blood 144(22):2319-2326, 2024. e-Pub 2024. PMID: 39316719.
- Pourebrahim R, Montoya RH, Akiyama H, Ostermann L, Khazaei S, Muftuoglu M, Baran N, Zhao R, Lesluyes T, Liu B, Khoury JD, Gagea M, Van Loo P, Andreeff M. Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice. Cell Rep Med 5(5):101558, 2024. e-Pub 2024. PMID: 38733986.
- Kuzmin E, Baker TM, Van Loo P, Glass L. Dynamics of karyotype evolution. Chaos 34(5), 2024. e-Pub 2024. PMID: 38717409.
- Kuzmin E, Baker TM, Lesluyes T, Monlong J, Abe KT, Coelho PP, Schwartz M, Del Corpo J, Zou D, Morin G, Pacis A, Yang Y, Martinez C, Barber J, Kuasne H, Li R, Bourgey M, Fortier AM, Davison PG, Omeroglu A, Guiot MC, Morris Q, Kleinman CL, Huang S, Gingras AC, Ragoussis J, Bourque G, Van Loo P, Park M. Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring. Cell Rep 43(4):113988, 2024. e-Pub 2024. PMID: 38517886.
- Woodcock DJ, Sahli A, Teslo R, Bhandari V, Gruber AJ, Ziubroniewicz A, Gundem G, Xu Y, Butler A, Anokian E, Pope BJ, Jung CH, Tarabichi M, Dentro SC, Farmery JHR, Prostate Group CI, Van Loo P, Warren AY, Gnanapragasam V, Hamdy FC, Bova GS, Foster CS, Neal DE, Lu YJ, Kote-Jarai Z, Fraser M, Bristow RG, Boutros PC, Costello AJ, Corcoran NM, Hovens CM, Massie CE, Lynch AG, Brewer DS, Eeles RA, Cooper CS, Wedge DC. Genomic evolution shapes prostate cancer disease type. Cell Genom 4(3):100511, 2024. e-Pub 2024. PMID: 38428419.
- Heeke S, Gay CM, Estecio MR, Tran H, Morris BB, Zhang B, Tang X, Raso MG, Rocha P, Lai S, Arriola E, Hofman P, Hofman V, Kopparapu P, Lovly CM, Concannon K, De Sousa LG, Lewis WE, Kondo K, Hu X, Tanimoto A, Vokes NI, Nilsson MB, Stewart A, Jansen M, Horváth I, Gaga M, Panagoulias V, Raviv Y, Frumkin D, Wasserstrom A, Shuali A, Schnabel CA, Xi Y, Diao L, Wang Q, Zhang J, Van Loo P, Wang J, Wistuba II, Byers LA, Heymach JV. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. Cancer Cell 42(2):225-237.e5, 2024. e-Pub 2024. PMID: 38278149.
- Huang KK, Ma H, Chong RHH, Uchihara T, Lian BSX, Zhu F, Sheng T, Srivastava S, Tay ST, Sundar R, Tan ALK, Ong X, Lee M, Ho SWT, Lesluyes T, Ashktorab H, Smoot D, Van Loo P, Chua JS, Ramnarayanan K, Lau LHS, Gotoda T, Kim HS, Ang TL, Khor C, Lee JWJ, Tsao SKK, Yang WL, Teh M, Chung H, So JBY, Yeoh KG, Tan P, Singapore Gastric Cancer Consortium. Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. Cancer Cell 41(12):2019-2037.e8, 2023. e-Pub 2023. PMID: 37890493.
- Hasan, AM, Cremaschi, P, Wetterskog, D, Jayaram, A, Wong, SQ, Williams, S, Pasam, A, Trigos, A, Trujillo, B, Grist, E, Friedrich, S, Vainauskas, O, Parry, M, Ismail, M, Devlies, W, Wingate, A, Linch, M, Naceur-Lombardelli, C, Zaccaria, S, Hessey, S, Shiu, KK, Bridgewater, J, Hochhauser, D, Forster, M, Lee, SM, Ahmad, T, Papadatos-Pastos, D, Janes, SM, Van Loo, P, Enfield, K, Mcgranahan, N, Huebner, A, Quezada, SA, Beck, S, Parker, PJ, Enver, T, Hynds, RE, Pearce, DR, Falzon, M, Proctor, I, Sinclair, R, Lok, Cw, Rhodes, Z, Moore, DA, Marafioti, T, Mitchison, M, Ellery, P, Sivakumar, M, Linch, M, Brandner, S, Rowan, AJ, Hiley, CT, Veeriah, S, Shaw, H, Naceur-Lombardelli, C, Toncheva, A, Prymas, P, Watkins, TB, Bailey, C, Martínez-Ruiz, C, Litchfield, K, Al-Bakir, M, Kanu, N, Ward, S, Lim, E, Reading, JL, Chain, B, Watkins, TB, Akay, M, Flanagan, AM, Biswas, D, Pich, O, Dietzen, M, Puttick, C, Colliver, E, Magness, A, Angelova, M, Black, JR, Lucas, O, Hill, W, Liu, WK, Frankell, AM, Magno, N, Athanasopoulou, F, Salgado, R, Lee, C, Grigoriadis, K, Al-Sawaf, O, Karasaki, T, Bunkum, A, Noorani, I, Benafif, S, Barbe, V, Bola, SK, Leone, G, Alifrangis, C, McGovern, U, Thol, K, Gamble, S, Ung, SK, Sahwangarrom, T, Marin, CP, Wong, S, Pawlik, P, Lam, JM, Richard, C, Vendramin, R, Dijkstra, K, Rane, J, Nicod, J, Dwornik, A, Bowles, K, Zaidi, R, Gishen, F, Stone, P, Stirling, C, Turajlic, S, Larkin, J, Pickering, L, Furness, AJ, Young, K, Drake, WM, Edmonds, K, Hunter, N, Mangwende, M, Pearce, K, Grostate, L, Au, L, Spain, L, Shepherd, ST, Yan, H, Shum, B, Tippu, Z, Hanley, B, Spencer, C, Emmerich, M, Gerard, CL, Schmitt, AM, Del Rosario, L, Carlyle, E, Lewis, C, Holt, L, Lucanas, A, O’Flaherty, M, Hazell, S, Mudhar, H, Messiou, C, Latifoltojar, A, Fendler, A, Byrne, F, Pallikonda, H, Lobon, I, Coulton, A, Cattin, AL, Deng, D, Feng, H, Rowan, A, Yousaf, N, Popat, S, Curtis, O, Milner-Watts, C, Stamp, G, Nye, E, Murra, A, Korteweg, J, Kelly, D, Terry, L, Biano, J, Peat, K, Kelly, K, Grieco, C, Le, ML, D’Arienzo, PD, Turay, E, Hill, P, Josephs, D, Irshad, S, Spicer, J, Mahadeva, U, Green, A, Stewart, R, Wright, N, Pulman, G, Mitu, R, Phillips-Boyd, S, Enting, D, Rudman, S, Ghosh, S, Karapanagiotou, E, Pintus, E, Tutt, A, Howlett, S, Brenton, JD, Caldas, C, Fitzgerald, RC, Jimenez-Linan, M, Provenzano, E, Cluroe, A, Paterson, A, Aitken, S, Allinson, K, Stewart, GD, McDermott, U, Beddowes, E, Maughan, TS, Ansorge, O, Campbell, PJ, Roxburgh, P, Fraser, S, Blyth, KG, Le Quesne, J, Krebs, M, Blackhall, FH, Summers, Y, Oliveira, P, Ortega-Franco, A, Dive, C, Gomes, F, Carter, M, Dransfield, J, Thomas, AL, Fennell, D, Shaw, J, Wilson, C, Marrone, D, Naidu, B, Baijal, S, Tanchel, B, Langman, G, Robinson, A, Collard, M, Cockcroft, P, Ferris, C, Bancroft, H, Kerr, A, Middleton, G, Webb, J, Kadiri, S, Colloby, P, Olisemeke, B, Wilson, R, Shackleford, H, Osman, A, Tomlinson, I, Jogai, S, Holden, S, Fernandes, T, McNeish, IA, Hampton, B, McKenzie, M, Hackshaw, A, Sharp, A, Chan, K, Farrelly, L, Bridger, H, Leslie, R, Tookman, A, Swanton, C, Jamal-Hanjani, M, Lise, S, Sandhu, S, Attard, G. Copy number architectures define treatment-mediated selection of lethal prostate cancer clones. Nature communications 14(1), 2023. e-Pub 2023. PMID: 37563129.
- Nurminen A, Jaatinen S, Taavitsainen S, Högnäs G, Lesluyes T, Ansari-Pour N, Tolonen T, Haase K, Koskenalho A, Kankainen M, Jasu J, Rauhala H, Kesäniemi J, Nikupaavola T, Kujala P, Rinta-Kiikka I, Riikonen J, Kaipia A, Murtola T, Tammela TL, Visakorpi T, Nykter M, Wedge DC, Van Loo P, Bova GS. Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine. Genome Med 15(1):82, 2023. e-Pub 2023. PMID: 37828555.
- Watkins TBK, Colliver EC, Huska MR, Kaufmann TL, Lim EL, Duncan CB, Haase K, Van Loo P, Swanton C, McGranahan N, Schwarz RF. Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity. PLoS Comput Biol 19(10):e1011379, 2023. e-Pub 2023. PMID: 37871126.
- O'Connor D, Demeulemeester J, Conde L, Kirkwood A, Fung K, Papaleonidopoulou F, Bloye G, Farah N, Rahman S, Hancock J, Bateman C, Inglott S, Mee J, Herrero J, Van Loo P, Moorman AV, Vora A, Mansour MR. The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia. J Clin Oncol 41(19):3545-3556, 2023. e-Pub 2023. PMID: 37098241.
- Abbosh, C, Frankell, AM, Harrison, T, Kisistok, J, Garnett, A, Johnson, L, Veeriah, S, Moreau, M, Chesh, A, Chaunzwa, TL, Weiss, J, Schroeder, MR, Ward, S, Grigoriadis, K, Shahpurwalla, A, Litchfield, K, Puttick, C, Biswas, D, Karasaki, T, Black, JR, Martínez-Ruiz, C, Bakir, MA, Pich, O, Watkins, TB, Lim, E, Huebner, A, Moore, DA, Godin-Heymann, N, L’Hernault, A, Bye, H, Odell, A, Roberts, P, Gomes, F, Patel, AJ, Manzano, E, Hiley, CT, Carey, N, Riley, J, Cook, DE, Hodgson, D, Stetson, D, Barrett, JC, Kortlever, RM, Evan, GI, Hackshaw, A, Daber, RD, Shaw, J, Van Loo, P, Pan, X, Yuan, Y. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616(7957):553-562, 2023. e-Pub 2023. PMID: 37055640.
- Ng, KW, Boumelha, J, Enfield, K, Almagro, J, Cha, H, Pich, O, Karasaki, T, Moore, DA, Salgado, R, Sivakumar, M, Young, GR, Molina-Arcas, M, de Carné Trécesson, S, Anastasiou, P, Fendler, A, Au, L, Shepherd, ST, Martínez-Ruiz, C, Puttick, C, Black, JR, Watkins, TB, Kim, H, Shim, S, Faulkner, N, Attig, J, Veeriah, S, Magno, N, Ward, S, Frankell, AM, Al-Bakir, M, Lim, E, Hill, MS, Wilson, GA, Cook, DE, Birkbak, NJ, Behrens, A, Yousaf, N, Popat, S, Hackshaw, A, Rowan, AJ, Huebner, A, Campbell, BB, Bailey, C, Lee, C, Biswas, D, Colliver, E, Athanasopoulou, F, Van Loo, P, Pan, X, Yuan, Y. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 616(7957):563-573, 2023. e-Pub 2023. PMID: 37046094.
- Hill, W, Lim, E, Weeden, CE, Lee, C, Augustine, M, Chen, K, Kuan, FC, Marongiu, F, Evans, EJ, Moore, DA, Rodrigues, FS, Pich, O, Bakker, B, Cha, H, Myers, R, van Maldegem, F, Boumelha, J, Veeriah, S, Rowan, AJ, Naceur-Lombardelli, C, Karasaki, T, Sivakumar, M, De, S, Caswell, DR, Nagano, A, Black, JR, Martínez-Ruiz, C, Ryu, MH, Huff, RD, Li, S, Favé, MJ, Magness, A, Suárez-Bonnet, A, Priestnall, SL, Lüchtenborg, M, Lavelle, K, Pethick, J, Hardy, S, McRonald, FE, Lin, MH, Troccoli, CI, Ghosh, M, Miller, YE, Merrick, DT, Keith, RL, Al-Bakir, M, Bailey, C, Van Loo, P, Pan, X, Yuan, Y. Lung adenocarcinoma promotion by air pollutants. Nature 616(7955):159-167, 2023. e-Pub 2023. PMID: 37020004.
- Al-Sawaf, O, Weiss, J, Skrzypski, M, Lam, JM, Karasaki, T, Zambrana, F, Kidd, AC, Frankell, AM, Watkins, TB, Martínez-Ruiz, C, Puttick, C, Black, JR, Huebner, A, Bakir, MA, Sokac, M, Collins, S, Veeriah, S, Magno, N, Naceur-Lombardelli, C, Prymas, P, Toncheva, A, Ward, S, Jayanth, N, Salgado, R, Bridge, CP, Christiani, DC, Mak, RH, Bay, C, Rosenthal, MH, Sattar, N, Welsh, P, Liu, Y, Perrimon, N, Popuri, K, Beg, MF, Mcgranahan, N, Hackshaw, A, Breen, DM, O'Rahilly, S, Birkbak, NJ, Aerts, HJ, Watkins, TB, Aerts, HJ, Lester, JF, Bajaj, A, Nakas, A, Sodha-Ramdeen, A, Van Loo, P, Pan, X, Yuan, Y. Body composition and lung cancer-associated cachexia in TRACERx. Nature medicine 29(4):846-858, 2023. e-Pub 2023. PMID: 37045997.
- Martínez-Ruiz C, Black JRM, Puttick C, Hill MS, Demeulemeester J, Larose Cadieux E, Thol K, Jones TP, Veeriah S, Naceur-Lombardelli C, Toncheva A, Prymas P, Rowan A, Ward S, Cubitt L, Athanasopoulou F, Pich O, Karasaki T, Moore DA, Salgado R, Colliver E, Castignani C, Dietzen M, Huebner A, Al Bakir M, Tanic M, Watkins TBK, Lim EL, Al-Rashed AM, Lang D, Clements J, Cook DE, Rosenthal R, Wilson GA, Frankell AM, de Carné Trécesson S, East P, Kanu N, Litchfield K, Birkbak NJ, Hackshaw A, Beck S, Van Loo P, Jamal-Hanjani M, TRACERx Consortium, Swanton C, McGranahan N. Genomic-transcriptomic evolution in lung cancer and metastasis. Nature 616(7957):543-552, 2023. e-Pub 2023. PMID: 37046093.
- Karasaki T, Moore DA, Veeriah S, Naceur-Lombardelli C, Toncheva A, Magno N, Ward S, Bakir MA, Watkins TBK, Grigoriadis K, Huebner A, Hill MS, Frankell AM, Abbosh C, Puttick C, Zhai H, Gimeno-Valiente F, Saghafinia S, Kanu N, Dietzen M, Pich O, Lim EL, Martínez-Ruiz C, Black JRM, Biswas D, Campbell BB, Lee C, Colliver E, Enfield KSS, Hessey S, Hiley CT, Zaccaria S, Litchfield K, Birkbak NJ, Cadieux EL, Demeulemeester J, Van Loo P, Adusumilli PS, Tan KS, Cheema W, Sanchez-Vega F, Jones DR, Rekhtman N, Travis WD, Hackshaw A, Marafioti T, Salgado R, Le Quesne J, Nicholson AG, TRACERx Consortium, McGranahan N, Swanton C, Jamal-Hanjani M. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nat Med 29(4):833-845, 2023. e-Pub 2023. PMID: 37045996.
- Frankell AM, Dietzen M, Al Bakir M, Lim EL, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A, Hill MS, Grigoriadis K, Moore DA, Black JRM, Liu WK, Thol K, Pich O, Watkins TBK, Naceur-Lombardelli C, Cook DE, Salgado R, Wilson GA, Bailey C, Angelova M, Bentham R, Martínez-Ruiz C, Abbosh C, Nicholson AG, Le Quesne J, Biswas D, Rosenthal R, Puttick C, Hessey S, Lee C, Prymas P, Toncheva A, Smith J, Xing W, Nicod J, Price G, Kerr KM, Naidu B, Middleton G, Blyth KG, Fennell DA, Forster MD, Lee SM, Falzon M, Hewish M, Shackcloth MJ, Lim E, Benafif S, Russell P, Boleti E, Krebs MG, Lester JF, Papadatos-Pastos D, Ahmad T, Thakrar RM, Lawrence D, Navani N, Janes SM, Dive C, Blackhall FH, Summers Y, Cave J, Marafioti T, Herrero J, Quezada SA, Peggs KS, Schwarz RF, Van Loo P, Miedema DM, Birkbak NJ, Hiley CT, Hackshaw A, Zaccaria S, TRACERx Consortium, Jamal-Hanjani M, McGranahan N, Swanton C. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 616(7957):525-533, 2023. e-Pub 2023. PMID: 37046096.
- Al Bakir M, Huebner A, Martínez-Ruiz C, Grigoriadis K, Watkins TBK, Pich O, Moore DA, Veeriah S, Ward S, Laycock J, Johnson D, Rowan A, Razaq M, Akther M, Naceur-Lombardelli C, Prymas P, Toncheva A, Hessey S, Dietzen M, Colliver E, Frankell AM, Bunkum A, Lim EL, Karasaki T, Abbosh C, Hiley CT, Hill MS, Cook DE, Wilson GA, Salgado R, Nye E, Stone RK, Fennell DA, Price G, Kerr KM, Naidu B, Middleton G, Summers Y, Lindsay CR, Blackhall FH, Cave J, Blyth KG, Nair A, Ahmed A, Taylor MN, Procter AJ, Falzon M, Lawrence D, Navani N, Thakrar RM, Janes SM, Papadatos-Pastos D, Forster MD, Lee SM, Ahmad T, Quezada SA, Peggs KS, Van Loo P, Dive C, Hackshaw A, Birkbak NJ, Zaccaria S, TRACERx Consortium, Jamal-Hanjani M, McGranahan N, Swanton C. The evolution of non-small cell lung cancer metastases in TRACERx. Nature 616(7957):534-542, 2023. e-Pub 2023. PMID: 37046095.
- Birkeälv S, Harland M, Matsuyama LSAS, Rashid M, Mehta I, Laye JP, Haase K, Mell T, Iyer V, Robles-Espinoza CD, McDermott U, van Loo P, Kuijjer ML, Possik PA, Maria Engler SS, Bishop DT, Newton-Bishop J, Adams DJ. Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. J Pathol 259(1):56-68, 2023. e-Pub 2023. PMID: 36219477.
- Buhigas, C, Warren, AY, Leung, WK, Whitaker, H, Luxton, HJ, Hawkins, S, Kay, J, Butler, A, Xu, Y, Woodcock, DJ, Merson, S, Frame, FM, Sahli, A, Abascal, F, Gihawi, A, Lambert, A, Thompson, A, Futreal, A, Menzies, A, Baddage, A, Ng, A, Sahil, A, Kremeyer, B, Al-Lazikani, B, Massie, C, Greenman, CD, Ogden, C, Verrill, C, Fisher, C, Berney, D, Burns, D, Leongamornlert, DA, Jones, D, Nicol, D, Wedge, D, Cahill, D, Easton, DF, Rowe, E, Riabchenko, E, Bancroft, EK, Mayer, E, Anokian, E, Hamdy, FC, Park, G, Pelvender, G, Leeman, G, Gundem, G, Zhang, H, Mills, IG, Van Loo, P. The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates. Molecular cancer 21(1), 2022. e-Pub 2022. PMID: 36131292.
- Kaufmann TL, Petkovic M, Watkins TBK, Colliver EC, Laskina S, Thapa N, Minussi DC, Navin N, Swanton C, Van Loo P, Haase K, Tarabichi M, Schwarz RF. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol 23(1):241, 2022. e-Pub 2022. PMID: 36376909.
- Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang W. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. Nat Biotechnol 40(11):1624-1633, 2022. e-Pub 2022. PMID: 35697807.
- Cross W, Lyskjær I, Lesluyes T, Hargreaves S, Strobl AC, Davies C, Waise S, Hames-Fathi S, Oukrif D, Ye H, Amary F, Tirabosco R, Gerrand C, Baker T, Barnes D, Steele C, Alexandrov L, Bond G, Genomics England Research Consortium, Cool P, Pillay N, Van Loo P, Flanagan AM. A genetic model for central chondrosarcoma evolution correlates with patient outcome. Genome Med 14(1):99, 2022. e-Pub 2022. PMID: 36042521.
- Wu, Y, Biswas, D, Usaite, I, Angelova, M, Boeing, S, Karasaki, T, Veeriah, S, Czyzewska-Khan, J, Morton, C, Joseph, M, Hessey, S, Reading, JL, Georgiou, A, Al-Bakir, M, Birkbak, NJ, Price, G, Khalil, M, Kerr, K, Richardson, S, Cheyne, H, Cruickshank, T, Wilson, GA, Rosenthal, R, Aerts, HJ, Hewish, M, Anand, G, Khan, SA, Lau, K, Sheaff, M, Schmid, P, Lim, L, Conibear, J, Schwarz, R, Kaufmann, TL, Huska, M, Shaw, J, Riley, J, Primrose, L, Fennell, D, Hackshaw, A, Ngai, Y, Sharp, A, Pressey, O, Smith, S, Gower, N, Dhanda, H, Chan, K, Chakraborty, S, Litchfield, K, Van Loo, P. A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer 3(6):696-709, 2022. e-Pub 2022. PMID: 35637401.
- Drews RM, Hernando B, Tarabichi M, Haase K, Lesluyes T, Smith PS, Morrill Gavarró L, Couturier DL, Liu L, Schneider M, Brenton JD, Van Loo P, Macintyre G, Markowetz F. A pan-cancer compendium of chromosomal instability. Nature 606(7916):976-983, 2022. e-Pub 2022. PMID: 35705807.
- Steele CD, Abbasi A, Islam SMA, Bowes AL, Khandekar A, Haase K, Hames-Fathi S, Ajayi D, Verfaillie A, Dhami P, McLatchie A, Lechner M, Light N, Shlien A, Malkin D, Feber A, Proszek P, Lesluyes T, Mertens F, Flanagan AM, Tarabichi M, Van Loo P, Alexandrov LB, Pillay N. Signatures of copy number alterations in human cancer. Nature 606(7916):984-991, 2022. e-Pub 2022. PMID: 35705804.
- Demeulemeester J, Dentro SC, Gerstung M, Van Loo P. Biallelic mutations in cancer genomes reveal local mutational determinants. Nat Genet 54(2):128-133, 2022. e-Pub 2022. PMID: 35145300.
- Tarabichi M, Demeulemeester J, Verfaillie A, Flanagan AM, Van Loo P, Konopka T. A pan-cancer landscape of somatic mutations in non-unique regions of the human genome. Nat Biotechnol 39(12):1589-1596, 2021. e-Pub 2021. PMID: 34282324.
- Ansari-Pour N, Zheng Y, Yoshimatsu TF, Sanni A, Ajani M, Reynier JB, Tapinos A, Pitt JJ, Dentro S, Woodard A, Rajagopal PS, Fitzgerald D, Gruber AJ, Odetunde A, Popoola A, Falusi AG, Babalola CP, Ogundiran T, Ibrahim N, Barretina J, Van Loo P, Chen M, White KP, Ojengbede O, Obafunwa J, Huo D, Wedge DC, Olopade OI. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nat Commun 12(1):6946, 2021. e-Pub 2021. PMID: 34836952.
- Álvarez EG, Demeulemeester J, Otero P, Jolly C, García-Souto D, Pequeño-Valtierra A, Zamora J, Tojo M, Temes J, Baez-Ortega A, Rodriguez-Martin B, Oitaben A, Bruzos AL, Martínez-Fernández M, Haase K, Zumalave S, Abal R, Rodríguez-Castro J, Rodriguez-Casanova A, Diaz-Lagares A, Li Y, Raine KM, Butler AP, Otero I, Ono A, Aikata H, Chayama K, Ueno M, Hayami S, Yamaue H, Maejima K, Blanco MG, Forns X, Rivas C, Ruiz-Bañobre J, Pérez-Del-Pulgar S, Torres-Ruiz R, Rodriguez-Perales S, Garaigorta U, Campbell PJ, Nakagawa H, Van Loo P, Tubio JMC. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture. Nat Commun 12(1):6910, 2021. e-Pub 2021. PMID: 34824211.
- Ottina E, Panova V, Doglio L, Kazachenka A, Cornish G, Kirkpatrick J, Attig J, Young GR, Litchfield K, Lesluyes T, Van Loo P, Swanton C, MacRae J, Tüting T, Kassiotis G. E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion. Oncogene 40(37):5567-5578, 2021. e-Pub 2021. PMID: 34145398.
- Turati VA, Guerra-Assunção JA, Potter NE, Gupta R, Ecker S, Daneviciute A, Tarabichi M, Webster AP, Ding C, May G, James C, Brown J, Conde L, Russell LJ, Ancliff P, Inglott S, Cazzaniga G, Biondi A, Hall GW, Lynch M, Hubank M, Macaulay I, Beck S, Van Loo P, Jacobsen SE, Greaves M, Herrero J, Enver T. Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia. Nat Cancer 2(8):835-852, 2021. e-Pub 2021. PMID: 34734190.
- Ross EM, Haase K, Van Loo P, Markowetz F. Allele-specific multi-sample copy number segmentation in ASCAT. Bioinformatics 37(13):1909-1911, 2021. e-Pub 2021. PMID: 32449758.
- Chatsirisupachai K, Lesluyes T, Paraoan L, Van Loo P, de Magalhães JP. An integrative analysis of the age-associated multi-omic landscape across cancers. Nat Commun 12(1):2345, 2021. e-Pub 2021. PMID: 33879792.
- Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, Yu K, Rubanova Y, Macintyre G, Demeulemeester J, Vázquez-García I, Kleinheinz K, Livitz DG, Malikic S, Donmez N, Sengupta S, Anur P, Jolly C, Cmero M, Rosebrock D, Schumacher SE, Fan Y, Fittall M, Drews RM, Yao X, Watkins TBK, Lee J, Schlesner M, Zhu H, Adams DJ, McGranahan N, Swanton C, Getz G, Boutros PC, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Martincorena I, Markowetz F, Mustonen V, Yuan K, Gerstung M, Spellman PT, Wang W, Morris QD, Wedge DC, Van Loo P, PCAWG Evolution and Heterogeneity Working Group, PCAWG Consortium. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184(8):2239-2254.e39, 2021. e-Pub 2021. PMID: 33831375.
- Minussi DC, Nicholson MD, Ye H, Davis A, Wang K, Baker T, Tarabichi M, Sei E, Du H, Rabbani M, Peng C, Hu M, Bai S, Lin YW, Schalck A, Multani A, Ma J, McDonald TO, Casasent A, Barrera A, Chen H, Lim B, Arun B, Meric-Bernstam F, Van Loo P, Michor F, Navin NE. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592(7853):302-308, 2021. e-Pub 2021. PMID: 33762732.
- Litchfield K, Reading JL, Puttick C, Thakkar K, Abbosh C, Bentham R, Watkins TBK, Rosenthal R, Biswas D, Rowan A, Lim E, Al Bakir M, Turati V, Guerra-Assunção JA, Conde L, Furness AJS, Saini SK, Hadrup SR, Herrero J, Lee SH, Van Loo P, Enver T, Larkin J, Hellmann MD, Turajlic S, Quezada SA, McGranahan N, Swanton C. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell 184(3):596-614.e14, 2021. e-Pub 2021. PMID: 33508232.
- Fittall MW, Lyskjaer I, Ellery P, Lombard P, Ijaz J, Strobl AC, Oukrif D, Tarabichi M, Sill M, Koelsche C, Mechtersheimer G, Demeulemeester J, Tirabosco R, Amary F, Campbell PJ, Pfister SM, Jones DT, Pillay N, Van Loo P, Behjati S, Flanagan AM. Drivers underpinning the malignant transformation of giant cell tumour of bone. J Pathol 252(4):433-440, 2020. e-Pub 2020. PMID: 32866294.
- Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, Moore DA, Grönroos E, Rowan A, Dewhurst SM, Demeulemeester J, Dentro SC, Horswell S, Au L, Haase K, Escudero M, Rosenthal R, Bakir MA, Xu H, Litchfield K, Lu WT, Mourikis TP, Dietzen M, Spain L, Cresswell GD, Biswas D, Lamy P, Nordentoft I, Harbst K, Castro-Giner F, Yates LR, Caramia F, Jaulin F, Vicier C, Tomlinson IPM, Brastianos PK, Cho RJ, Bastian BC, Dyrskjøt L, Jönsson GB, Savas P, Loi S, Campbell PJ, Andre F, Luscombe NM, Steeghs N, Tjan-Heijnen VCG, Szallasi Z, Turajlic S, Jamal-Hanjani M, Van Loo P, Bakhoum SF, Schwarz RF, McGranahan N, Swanton C. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587(7832):126-132, 2020. e-Pub 2020. PMID: 32879494.
- Voordeckers K, Colding C, Grasso L, Pardo B, Hoes L, Kominek J, Gielens K, Dekoster K, Gordon J, Van der Zande E, Bircham P, Swings T, Michiels J, Van Loo P, Nuyts S, Pasero P, Lisby M, Verstrepen KJ. Ethanol exposure increases mutation rate through error-prone polymerases. Nat Commun 11(1):3664, 2020. e-Pub 2020. PMID: 32694532.
- Pladsen AV, Nilsen G, Rueda OM, Aure MR, Ø B, Liestøl K, Vitelli V, Frigessi A, Langerød A, Mathelier A, OSBREAC, Engebråten O, Kristensen V, Wedge DC, Van Loo P, Caldas C, Børresen-Dale AL, Russnes HG, Lingjærde OC. DNA copy number motifs are strong and independent predictors of survival in breast cancer. Commun Biol 3(1):153, 2020. e-Pub 2020. PMID: 32242091.
- Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, Detering H, Li Y, Rodriguez-Castro J, Dueso-Barroso A, Bruzos AL, Dentro SC, Blanco MG, Contino G, Ardeljan D, Tojo M, Roberts ND, Zumalave S, Edwards PAW, Weischenfeldt J, Puiggròs M, Chong Z, Chen K, Lee EA, Wala JA, Raine K, Butler A, Waszak SM, Navarro FCP, Schumacher SE, Monlong J, Maura F, Bolli N, Bourque G, Gerstein M, Park PJ, Wedge DC, Beroukhim R, Torrents D, Korbel JO, Martincorena I, Fitzgerald RC, Van Loo P, Kazazian HH, Burns KH, PCAWG Structural Variation Working Group, Campbell PJ, Tubio JMC, PCAWG Consortium. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet 52(3):306-319, 2020. e-Pub 2020. PMID: 32024998.
- López S, Lim EL, Horswell S, Haase K, Huebner A, Dietzen M, Mourikis TP, Watkins TBK, Rowan A, Dewhurst SM, Birkbak NJ, Wilson GA, Van Loo P, Jamal-Hanjani M, Consortium T, Swanton C, McGranahan N. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genet 52(3):283-293, 2020. e-Pub 2020. PMID: 32139907.
- Rubanova Y, Shi R, Harrigan CF, Li R, Wintersinger J, Sahin N, Deshwar A, PCAWG Evolution and Heterogeneity Working Group, Morris Q, PCAWG Consortium. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun 11(1):731, 2020. e-Pub 2020. PMID: 32024834.
- Cmero M, Yuan K, Ong CS, Schröder J, PCAWG Evolution and Heterogeneity Working Group, Corcoran NM, Papenfuss T, Hovens CM, Markowetz F, Macintyre G, PCAWG Consortium. Inferring structural variant cancer cell fraction. Nat Commun 11(1):730, 2020. e-Pub 2020. PMID: 32024845.
- Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD, PCAWG Evolution and Heterogeneity Working Group, Spellman PT, Wedge DC, Van Loo P, PCAWG Consortium. The evolutionary history of 2,658 cancers. Nature 578(7793):122-128, 2020. e-Pub 2020. PMID: 32025013.
- ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578(7793):82-93, 2020. e-Pub 2020. PMID: 32025007.
- Salcedo A, Tarabichi M, Espiritu SMG, Deshwar AG, David M, Wilson NM, Dentro S, Wintersinger JA, Liu LY, Ko M, Sivanandan S, Zhang H, Zhu K, Ou Yang TH, Chilton JM, Buchanan A, Lalansingh CM, P'ng C, Anghel CV, Umar I, Lo B, Zou W, Participants DS, Simpson JT, Stuart JM, Anastassiou D, Guan Y, Ewing AD, Ellrott K, Wedge DC, Morris Q, Van Loo P, Boutros PC. A community effort to create standards for evaluating tumor subclonal reconstruction. Nat Biotechnol 38(1):97-107, 2020. e-Pub 2020. PMID: 31919445.
- Steele CD, Tarabichi M, Oukrif D, Webster AP, Ye H, Fittall M, Lombard P, Martincorena I, Tarpey PS, Collord G, Haase K, Strauss SJ, Berisha F, Vaikkinen H, Dhami P, Jansen M, Behjati S, Amary MF, Tirabosco R, Feber A, Campbell PJ, Alexandrov LB, Van Loo P, Flanagan AM, Pillay N. Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways. Cancer Cell 35(3):441-456.e8, 2019. e-Pub 2019. PMID: 30889380.
- Rosenthal R, Cadieux EL, Salgado R, Bakir MA, Moore DA, Hiley CT, Lund T, Tanic M, Reading JL, Joshi K, Henry JY, Ghorani E, Wilson GA, Birkbak NJ, Jamal-Hanjani M, Veeriah S, Szallasi Z, Loi S, Hellmann MD, Feber A, Chain B, Herrero J, Quezada SA, Demeulemeester J, Van Loo P, Beck S, McGranahan N, Swanton C, TRACERx consortium. Neoantigen-directed immune escape in lung cancer evolution. Nature 567(7749):479-485, 2019. e-Pub 2019. PMID: 30894752.
- Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Ø G, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V. Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Med 10(1):92, 2018. e-Pub 2018. PMID: 30497530.
- Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, Ajani M, Johnson RS, Fitzgerald D, Grundstad AJ, Tuteja JH, Khramtsova G, Zhang J, Sveen E, Hwang B, Clayton W, Nkwodimmah C, Famooto B, Obasi E, Aderoju V, Oludara M, Omodele F, Akinyele O, Adeoye A, Ogundiran T, Babalola C, MacIsaac K, Popoola A, Morrissey MP, Chen LS, Wang J, Olopade CO, Falusi AG, Winckler W, Haase K, Van Loo P, Obafunwa J, Papoutsakis D, Ojengbede O, Weber B, Ibrahim N, White KP, Huo D, Olopade OI, Barretina J. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun 9(1):4181, 2018. e-Pub 2018. PMID: 30327465.
- Fittall MW, Mifsud W, Pillay N, Ye H, Strobl AC, Verfaillie A, Demeulemeester J, Zhang L, Berisha F, Tarabichi M, Young MD, Miranda E, Tarpey PS, Tirabosco R, Amary F, Grigoriadis AE, Stratton MR, Van Loo P, Antonescu CR, Campbell PJ, Flanagan AM, Behjati S. Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nat Commun 9(1):2150, 2018. e-Pub 2018. PMID: 29858576.
- Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, Verrill C, Berney DM, Dennis N, Merson S, Hawkins S, Howat W, Lu YJ, Lambert A, Kay J, Kremeyer B, Karaszi K, Luxton H, Camacho N, Marsden L, Edwards S, Matthews L, Bo V, Leongamornlert D, McLaren S, Ng A, Yu Y, Zhang H, Dadaev T, Thomas S, Easton DF, Ahmed M, Bancroft E, Fisher C, Livni N, Nicol D, Tavaré S, Gill P, Greenman C, Khoo V, Van As N, Kumar P, Ogden C, Cahill D, Thompson A, Mayer E, Rowe E, Dudderidge T, Gnanapragasam V, Shah NC, Raine K, Jones D, Menzies A, Stebbings L, Teague J, Hazell S, Corbishley C, CAMCAP Study Group, de Bono J, Attard G, Isaacs W, Visakorpi T, Fraser M, Boutros PC, Bristow RG, Workman P, Sander C, TCGA Consortium, Hamdy FC, Futreal A, McDermott U, Al-Lazikani B, Lynch AG, Bova GS, Foster CS, Brewer DS, Neal DE, Cooper CS, Eeles RA. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nat Genet 50(5):682-692, 2018. e-Pub 2018. PMID: 29662167.
- Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C, TRACERx Renal Consortium. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell 173(3):595-610.e11, 2018. e-Pub 2018. PMID: 29656894.
- McGranahan N, Rosenthal R, Hiley CT, Rowan AJ, Watkins TBK, Wilson GA, Birkbak NJ, Veeriah S, Van Loo P, Herrero J, Swanton C, TRACERx Consortium. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell 171(6):1259-1271.e11, 2017. e-Pub 2017. PMID: 29107330.
- Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, Van Loo P, Davies H, Stratton MR, Campbell PJ. Universal Patterns of Selection in Cancer and Somatic Tissues. Cell 171(5):1029-1041.e21, 2017. e-Pub 2017. PMID: 29056346.
- Cheng J, Demeulemeester J, Wedge DC, Vollan HKM, Pitt JJ, Russnes HG, Pandey BP, Nilsen G, Nord S, Bignell GR, White KP, Børresen-Dale AL, Campbell PJ, Kristensen VN, Stratton MR, Lingjærde OC, Moreau Y, Van Loo P. Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nat Commun 8(1):1221, 2017. e-Pub 2017. PMID: 29089486.
- Camacho N, Van Loo P, Edwards S, Kay JD, Matthews L, Haase K, Clark J, Dennis N, Thomas S, Kremeyer B, Zamora J, Butler AP, Gundem G, Merson S, Luxton H, Hawkins S, Ghori M, Marsden L, Lambert A, Karaszi K, Pelvender G, Massie CE, Kote-Jarai Z, Raine K, Jones D, Howat WJ, Hazell S, Livni N, Fisher C, Ogden C, Kumar P, Thompson A, Nicol D, Mayer E, Dudderidge T, Yu Y, Zhang H, Shah NC, Gnanapragasam VJ, CRUK-ICGC Prostate Group, Isaacs W, Visakorpi T, Hamdy F, Berney D, Verrill C, Warren AY, Wedge DC, Lynch AG, Foster CS, Lu YJ, Bova GS, Whitaker HC, McDermott U, Neal DE, Eeles R, Cooper CS, Brewer DS. Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. PLoS Genet 13(9):e1007001, 2017. e-Pub 2017. PMID: 28945760.
- Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M, Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C, Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW, Richardson AL, Tutt A, Lønning PE, Campbell PJ. Genomic Evolution of Breast Cancer Metastasis and Relapse. Cancer Cell 32(2):169-184.e7, 2017. e-Pub 2017. PMID: 28810143.
- Behjati S, Tarpey PS, Haase K, Ye H, Young MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I, Cooke SL, Davies H, Mifsud W, Lidgren M, Martin S, Latimer C, Maddison M, Butler AP, Teague JW, Pillay N, Shlien A, McDermott U, Futreal PA, Baumhoer D, Zaikova O, Bjerkehagen B, Myklebost O, Amary MF, Tirabosco R, Van Loo P, Stratton MR, Flanagan AM, Campbell PJ. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nat Commun 8:15936, 2017. e-Pub 2017. PMID: 28643781.
- Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, Salm M, Horswell S, Escudero M, Matthews N, Rowan A, Chambers T, Moore DA, Turajlic S, Xu H, Lee SM, Forster MD, Ahmad T, Hiley CT, Abbosh C, Falzon M, Borg E, Marafioti T, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Shah R, Joseph L, Quinn AM, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Dentro S, Taniere P, O'Sullivan B, Lowe HL, Hartley JA, Iles N, Bell H, Ngai Y, Shaw JA, Herrero J, Szallasi Z, Schwarz RF, Stewart A, Quezada SA, Le Quesne J, Van Loo P, Dive C, Hackshaw A, Swanton C, TRACERx Consortium. Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med 376(22):2109-2121, 2017. e-Pub 2017. PMID: 28445112.
- Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, HJWL A, Hackshaw A, Shaw JA, Zimmermann BG, TRACERx consortium, PEACE consortium, Swanton C. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545(7655):446-451, 2017. e-Pub 2017. PMID: 28445469.
- Grove CS, Bolli N, Manes N, Varela I, Van't Veer M, Bench A, Eldaly H, Wedge D, Van Loo P, Vassiliou GS. Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution. Br J Haematol 176(5):825-829, 2017. e-Pub 2017. PMID: 27062498.
- Demeulemeester J, Kumar P, Møller EK, Nord S, Wedge DC, Peterson A, Mathiesen RR, Fjelldal R, Zamani Esteki M, Theunis K, Fernandez Gallardo E, Grundstad AJ, Borgen E, Baumbusch LO, Børresen-Dale AL, White KP, Kristensen VN, Van Loo P, Voet T, Naume B. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biol 17(1):250, 2016. e-Pub 2016. PMID: 27931250.
- Raine KM, Van Loo P, Wedge DC, Jones D, Menzies A, Butler AP, Teague JW, Tarpey P, Nik-Zainal S, Campbell PJ. ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data. Curr Protoc Bioinformatics 56:15.9.1-15.9.17, 2016. e-Pub 2016. PMID: 27930809.
- Alexandrov LB, Ju YS, Haase K, Van Loo P, Martincorena I, Nik-Zainal S, Totoki Y, Fujimoto A, Nakagawa H, Shibata T, Campbell PJ, Vineis P, Phillips DH, Stratton MR. Mutational signatures associated with tobacco smoking in human cancer. Science 354(6312):618-622, 2016. e-Pub 2016. PMID: 27811275.
- Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H, Nik-Zainal S, Hardy C, Latimer C, Raine KM, Stebbings L, Menzies A, Jones D, Shepherd R, Butler AP, Teague JW, Jorgensen M, Khatri B, Pillay N, Shlien A, Futreal PA, Badie C, ICGC Prostate Group, McDermott U, Bova GS, Richardson AL, Flanagan AM, Stratton MR, Campbell PJ. Mutational signatures of ionizing radiation in second malignancies. Nat Commun 7:12605, 2016. e-Pub 2016. PMID: 27615322.
- Sandhu V, Wedge DC, Bowitz Lothe IM, Labori KJ, Dentro SC, Buanes T, Skrede ML, Dalsgaard AM, Munthe E, Myklebost O, Lingjærde OC, Børresen-Dale AL, Ikdahl T, Van Loo P, Nord S, Kure EH. The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma. Cancer Res 76(17):5092-102, 2016. e-Pub 2016. PMID: 27488532.
- Shlien A, Raine K, Fuligni F, Arnold R, Nik-Zainal S, Dronov S, Mamanova L, Rosic A, Ju YS, Cooke SL, Ramakrishna M, Papaemmanuil E, Davies HR, Tarpey PS, Van Loo P, Wedge DC, Jones DR, Martin S, Marshall J, Anderson E, Hardy C, ICGC Breast Cancer Working Group, Oslo Breast Cancer Research Consortium, Barbashina V, Aparicio SA, Sauer T, Ø G, Vincent-Salomon A, Mariani O, Boyault S, Fatima A, Langerød A, Å B, Thomas G, Richardson AL, Børresen-Dale AL, Polyak K, Stratton MR, Campbell PJ. Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer. Cell Rep 16(7):2032-46, 2016. e-Pub 2016. PMID: 27498871.
- Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O'Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, Döhner K, Schlenk RF, Döhner H, Campbell PJ. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med 374(23):2209-2221, 2016. e-Pub 2016. PMID: 27276561.
- Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Å B, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534(7605):47-54, 2016. e-Pub 2016. PMID: 27135926.
- Desmedt C, Zoppoli G, Gundem G, Pruneri G, Larsimont D, Fornili M, Fumagalli D, Brown D, Rothé F, Vincent D, Kheddoumi N, Rouas G, Majjaj S, Brohée S, Van Loo P, Maisonneuve P, Salgado R, Van Brussel T, Lambrechts D, Bose R, Metzger O, Galant C, Bertucci F, Piccart-Gebhart M, Viale G, Biganzoli E, Campbell PJ, Sotiriou C. Genomic Characterization of Primary Invasive Lobular Breast Cancer. J Clin Oncol 34(16):1872-81, 2016. e-Pub 2016. PMID: 26926684.
- Nielsen HM, How-Kit A, Guerin C, Castinetti F, Vollan HK, De Micco C, Daunay A, Taieb D, Van Loo P, Besse C, Kristensen VN, Hansen LL, Barlier A, Sebag F, Tost J. Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors. Endocr Relat Cancer 22(6):953-67, 2015. e-Pub 2015. PMID: 26400872.
- Sala Frigerio C, Lau P, Troakes C, Deramecourt V, Gele P, Van Loo P, Voet T, De Strooper B. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients. Alzheimers Dement 11(11):1265-76, 2015. e-Pub 2015. PMID: 25937274.
- Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, Lønning PE, Wedge DC, Campbell PJ. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21(7):751-9, 2015. e-Pub 2015. PMID: 26099045.
- Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, Stebbings L, Menzies A, Widaa S, Stratton MR, Jones PH, Campbell PJ. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348(6237):880-6, 2015. e-Pub 2015. PMID: 25999502.
- Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JMC, Papaemmanuil E, Brewer DS, Kallio HML, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O'Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC, ICGC Prostate Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS. The evolutionary history of lethal metastatic prostate cancer. Nature 520(7547):353-357, 2015. e-Pub 2015. PMID: 25830880.
- Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun 6:6605, 2015. e-Pub 2015. PMID: 25827447.
- Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell PJ, Jundt G, Hamoudi R, Wedge DC, Van Loo P, Hassan AB, Khatri B, Ye H, Tirabosco R, Amary MF, Flanagan AM. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res 1(2):113-23, 2015. e-Pub 2015. PMID: 27499898.
- Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem G, Alexandrov LB, Kremeyer B, Butler A, Lynch AG, Camacho N, Massie CE, Kay J, Luxton HJ, Edwards S, Kote-Jarai Z, Dennis N, Merson S, Leongamornlert D, Zamora J, Corbishley C, Thomas S, Nik-Zainal S, O'Meara S, Matthews L, Clark J, Hurst R, Mithen R, Bristow RG, Boutros PC, Fraser M, Cooke S, Raine K, Jones D, Menzies A, Stebbings L, Hinton J, Teague J, McLaren S, Mudie L, Hardy C, Anderson E, Joseph O, Goody V, Robinson B, Maddison M, Gamble S, Greenman C, Berney D, Hazell S, Livni N, ICGC Prostate Group, Fisher C, Ogden C, Kumar P, Thompson A, Woodhouse C, Nicol D, Mayer E, Dudderidge T, Shah NC, Gnanapragasam V, Voet T, Campbell P, Futreal A, Easton D, Warren AY, Foster CS, Stratton MR, Whitaker HC, McDermott U, Brewer DS, Neal DE. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet 47(4):367-372, 2015. e-Pub 2015. PMID: 25730763.
- Shlien A, Campbell BB, de Borja R, Alexandrov LB, Merico D, Wedge D, Van Loo P, Tarpey PS, Coupland P, Behjati S, Pollett A, Lipman T, Heidari A, Deshmukh S, Avitzur N, Meier B, Gerstung M, Hong Y, Merino DM, Ramakrishna M, Remke M, Arnold R, Panigrahi GB, Thakkar NP, Hodel KP, Henninger EE, Göksenin AY, Bakry D, Charames GS, Druker H, Lerner-Ellis J, Mistry M, Dvir R, Grant R, Elhasid R, Farah R, Taylor GP, Nathan PC, Alexander S, Ben-Shachar S, Ling SC, Gallinger S, Constantini S, Dirks P, Huang A, Scherer SW, Grundy RG, Durno C, Aronson M, Gartner A, Meyn MS, Taylor MD, Pursell ZF, Pearson CE, Malkin D, Futreal PA, Stratton MR, Bouffet E, Hawkins C, Campbell PJ, Tabori U, Biallelic Mismatch Repair Deficiency Consortium. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat Genet 47(3):257-62, 2015. e-Pub 2015. PMID: 25642631.
- Borge KS, Nord S, Van Loo P, Lingjærde OC, Gunnes G, Alnæs GI, Solvang HK, Lüders T, Kristensen VN, Børresen-Dale AL, Lingaas F. Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN. PLoS One 10(5):e0126371, 2015. e-Pub 2015. PMID: 25955013.
- Rashid NU, Sperling AS, Bolli N, Wedge DC, Van Loo P, Tai YT, Shammas MA, Fulciniti M, Samur MK, Richardson PG, Magrangeas F, Minvielle S, Futreal PA, Anderson KC, Avet-Loiseau H, Campbell PJ, Parmigiani G, Munshi NC. Differential and limited expression of mutant alleles in multiple myeloma. Blood 124(20):3110-7, 2014. e-Pub 2014. PMID: 25237203.
- de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan AJ, Grönroos E, Muhammad MA, Horswell S, Gerlinger M, Varela I, Jones D, Marshall J, Voet T, Van Loo P, Rassl DM, Rintoul RC, Janes SM, Lee SM, Forster M, Ahmad T, Lawrence D, Falzon M, Capitanio A, Harkins TT, Lee CC, Tom W, Teefe E, Chen SC, Begum S, Rabinowitz A, Phillimore B, Spencer-Dene B, Stamp G, Szallasi Z, Matthews N, Stewart A, Campbell P, Swanton C. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346(6206):251-6, 2014. e-Pub 2014. PMID: 25301630.
- Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E, Knappskog S, Van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP, Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O'Meara S, Anderson E, Maddison M, Gamble S, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C, Neal D, Lynch AG, Visakorpi T, Isaacs WB, Veer LV, Caldas C, Desmedt C, Sotiriou C, Aparicio S, Foekens JA, Eyfjörd JE, Lakhani SR, Thomas G, Myklebost O, Span PN, Børresen-Dale AL, Richardson AL, Van de Vijver M, Vincent-Salomon A, Van den Eynden GG, Flanagan AM, Futreal PA, Janes SM, Bova GS, Stratton MR, McDermott U, Campbell PJ, ICGC Breast Cancer Group, ICGC Bone Cancer Group, ICGC Prostate Cancer Group. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 345(6196):1251343, 2014. e-Pub 2014. PMID: 25082706.
- Li Y, Schwab C, Ryan S, Papaemmanuil E, Robinson HM, Jacobs P, Moorman AV, Dyer S, Borrow J, Griffiths M, Heerema NA, Carroll AJ, Talley P, Bown N, Telford N, Ross FM, Gaunt L, McNally RJQ, Young BD, Sinclair P, Rand V, Teixeira MR, Joseph O, Robinson B, Maddison M, Dastugue N, Vandenberghe P, Stephens PJ, Cheng J, Van Loo P, Stratton MR, Campbell PJ, Harrison CJ. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature 508(7494):98-102, 2014. e-Pub 2014. PMID: 24670643.
- Behjati S, Tarpey PS, Sheldon H, Martincorena I, Van Loo P, Gundem G, Wedge DC, Ramakrishna M, Cooke SL, Pillay N, Vollan HKM, Papaemmanuil E, Koss H, Bunney TD, Hardy C, Joseph OR, Martin S, Mudie L, Butler A, Teague JW, Patil M, Steers G, Cao Y, Gumbs C, Ingram D, Lazar AJ, Little L, Mahadeshwar H, Protopopov A, Al Sannaa GA, Seth S, Song X, Tang J, Zhang J, Ravi V, Torres KE, Khatri B, Halai D, Roxanis I, Baumhoer D, Tirabosco R, Amary MF, Boshoff C, McDermott U, Katan M, Stratton MR, Futreal PA, Flanagan AM, Harris A, Campbell PJ. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet 46(4):376-379, 2014. e-Pub 2014. PMID: 24633157.
- Quigley DA, Fiorito E, Nord S, Van Loo P, Alnæs GG, Fleischer T, Tost J, Moen Vollan HK, Tramm T, Overgaard J, Bukholm IR, Hurtado A, Balmain A, Børresen-Dale AL, Kristensen V. The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors. Mol Oncol 8(2):273-84, 2014. e-Pub 2014. PMID: 24388359.
- Papaemmanuil E, Rapado I, Li Y, Potter NE, Wedge DC, Tubio J, Alexandrov LB, Van Loo P, Cooke SL, Marshall J, Martincorena I, Hinton J, Gundem G, van Delft FW, Nik-Zainal S, Jones DR, Ramakrishna M, Titley I, Stebbings L, Leroy C, Menzies A, Gamble J, Robinson B, Mudie L, Raine K, O'Meara S, Teague JW, Butler AP, Cazzaniga G, Biondi A, Zuna J, Kempski H, Muschen M, Ford AM, Stratton MR, Greaves M, Campbell PJ. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet 46(2):116-25, 2014. e-Pub 2014. PMID: 24413735.
- Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, Dawson KJ, Iorio F, Nik-Zainal S, Bignell GR, Hinton JW, Li Y, Tubio JM, McLaren S, O' Meara S, Butler AP, Teague JW, Mudie L, Anderson E, Rashid N, Tai YT, Shammas MA, Sperling AS, Fulciniti M, Richardson PG, Parmigiani G, Magrangeas F, Minvielle S, Moreau P, Attal M, Facon T, Futreal PA, Anderson KC, Campbell PJ, Munshi NC. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:2997, 2014. e-Pub 2014. PMID: 24429703.
- Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, Avezov E, Li J, Kollmann K, Kent DG, Aziz A, Godfrey AL, Hinton J, Martincorena I, Van Loo P, Jones AV, Guglielmelli P, Tarpey P, Harding HP, Fitzpatrick JD, Goudie CT, Ortmann CA, Loughran SJ, Raine K, Jones DR, Butler AP, Teague JW, O'Meara S, McLaren S, Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, Du MQ, Greaves M, Bowen D, Huntly BJP, Harrison CN, Cross NCP, Ron D, Vannucchi AM, Papaemmanuil E, Campbell PJ, Green AR. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369(25):2391-2405, 2013. e-Pub 2013. PMID: 24325359.
- Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goodie V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45(12):1479-82, 2013. e-Pub 2013. PMID: 24162739.
- Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, Yoon CJ, Ellis P, Wedge DC, Pellagatti A, Shlien A, Groves MJ, Forbes SA, Raine K, Hinton J, Mudie LJ, McLaren S, Hardy C, Latimer C, Della Porta MG, O'Meara S, Ambaglio I, Galli A, Butler AP, Walldin G, Teague JW, Quek L, Sternberg A, Gambacorti-Passerini C, Cross NC, Green AR, Boultwood J, Vyas P, Hellstrom-Lindberg E, Bowen D, Cazzola M, Stratton MR, Campbell PJ, Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122(22):3616-27; quiz 3699, 2013. e-Pub 2013. PMID: 24030381.
- Tarpey PS, Behjati S, Cooke SL, Van Loo P, Wedge DC, Pillay N, Marshall J, O'Meara S, Davies H, Nik-Zainal S, Beare D, Butler A, Gamble J, Hardy C, Hinton J, Jia MM, Jayakumar A, Jones D, Latimer C, Maddison M, Martin S, McLaren S, Menzies A, Mudie L, Raine K, Teague JW, Tubio JM, Halai D, Tirabosco R, Amary F, Campbell PJ, Stratton MR, Flanagan AM, Futreal PA. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 45(8):923-6, 2013. e-Pub 2013. PMID: 23770606.
- Voet T, Kumar P, Van Loo P, Cooke SL, Marshall J, Lin ML, Zamani Esteki M, Van der Aa N, Mateiu L, McBride DJ, Bignell GR, McLaren S, Teague J, Butler A, Raine K, Stebbings LA, Quail MA, D'Hooghe T, Moreau Y, Futreal PA, Stratton MR, Vermeesch JR, Campbell PJ. Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res 41(12):6119-38, 2013. e-Pub 2013. PMID: 23630320.
- Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 123(7):2965-8, 2013. e-Pub 2013. PMID: 23778141.
- Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J, Wlodarska I, De Wolf-Peeters C, Sagaert X, Tousseyn T. Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant 13(5):1305-16, 2013. e-Pub 2013. PMID: 23489474.
- Møller EK, Kumar P, Voet T, Peterson A, Van Loo P, Mathiesen RR, Fjelldal R, Grundstad J, Borgen E, Baumbusch LO, Naume B, Børresen-Dale AL, White KP, Nord S, Kristensen VN. Next-generation sequencing of disseminated tumor cells. Front Oncol 3:320, 2013. e-Pub 2013. PMID: 24427740.
- Yen J, White RM, Wedge DC, Van Loo P, de Ridder J, Capper A, Richardson J, Jones D, Raine K, Watson IR, Wu CJ, Cheng J, Martincorena I, Nik-Zainal S, Mudie L, Moreau Y, Marshall J, Ramakrishna M, Tarpey P, Shlien A, Whitmore I, Gamble S, Latimer C, Langdon E, Kaufman C, Dovey M, Taylor A, Menzies A, McLaren S, O'Meara S, Butler A, Teague J, Lister J, Chin L, Campbell P, Adams DJ, Zon LI, Patton EE, Stemple DL, Futreal PA. The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol 14(10):R113, 2013. e-Pub 2013. PMID: 24148783.
- Urbankova H, Baens M, Michaux L, Tousseyn T, Rack K, Katrincsakova B, Ferreiro JF, van Loo P, de Kelver W, Dierickx D, Demuynck H, Delannoy A, Verschuere J, Jarošová M, de Wolf-Peeters C, Vandenberghe P, Wlodarska I. Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes. Leuk Lymphoma 53(12):2449-55, 2012. e-Pub 2012. PMID: 22553924.
- Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC. Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 13:591, 2012. e-Pub 2012. PMID: 23442169.
- Cowin PA, George J, Fereday S, Loehrer E, Van Loo P, Cullinane C, Etemadmoghadam D, Ftouni S, Galletta L, Anglesio MS, Hendley J, Bowes L, Sheppard KE, Christie EL, Pearson RB, Harnett PR, Heinzelmann-Schwarz V, Friedlander M, McNally O, Quinn M, Campbell P, deFazio A, Bowtell DD, Australian Ovarian Cancer Study. LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Res 72(16):4060-73, 2012. e-Pub 2012. PMID: 22896685.
- Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jönsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerød A, Tutt A, Martens JW, Aparicio SA, Å B, Salomon AV, Thomas G, Børresen-Dale AL, Richardson AL, Neuberger MS, Futreal PA, Campbell PJ, Stratton MR, Breast Cancer Working Group of the International Cancer Genome Consortium. Mutational processes molding the genomes of 21 breast cancers. Cell 149(5):979-93, 2012. e-Pub 2012. PMID: 22608084.
- Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M, Shlien A, Cooke SL, Hinton J, Menzies A, Stebbings LA, Leroy C, Jia M, Rance R, Mudie LJ, Gamble SJ, Stephens PJ, McLaren S, Tarpey PS, Papaemmanuil E, Davies HR, Varela I, McBride DJ, Bignell GR, Leung K, Butler AP, Teague JW, Martin S, Jönsson G, Mariani O, Boyault S, Miron P, Fatima A, Langerød A, Aparicio SA, Tutt A, Sieuwerts AM, Å B, Thomas G, Salomon AV, Richardson AL, Børresen-Dale AL, Futreal PA, Stratton MR, Campbell PJ, Breast Cancer Working Group of the International Cancer Genome Consortium. The life history of 21 breast cancers. Cell 149(5):994-1007, 2012. e-Pub 2012. PMID: 22608083.
- Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerød A, Oslo Breast Cancer Consortium, Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van de Vijver M, van 't Veer L, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Børresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR. The landscape of cancer genes and mutational processes in breast cancer. Nature 486(7403):400-4, 2012. e-Pub 2012. PMID: 22722201.
- Stewart DR, Pemov A, Van Loo P, Beert E, Brems H, Sciot R, Claes K, Pak E, Dutra A, Lee CC, Legius E. Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors. Genes Chromosomes Cancer 51(5):429-37, 2012. e-Pub 2012. PMID: 22250039.
- Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Å H, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proc Natl Acad Sci U S A 109(8):2802-7, 2012. e-Pub 2012. PMID: 21908711.
- Wibom C, Ghasimi S, Van Loo P, Brännström T, Trygg J, Lau C, Henriksson R, Bergenheim T, Andersson U, Rydén P, Melin B. EGFR gene variants are associated with specific somatic aberrations in glioma. PLoS One 7(12):e47929, 2012. e-Pub 2012. PMID: 23236348.
- Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J. Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol 30(1):61-8, 2011. e-Pub 2011. PMID: 22178994.
- Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science 331(6016):468-72, 2011. e-Pub 2011. PMID: 21273489.
- Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, Perou CM, Børresen-Dale AL, Kristensen VN. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 107(39):16910-5, 2010. e-Pub 2010. PMID: 20837533.
- Thienpont B, Zhang L, Postma AV, Breckpot J, Tranchevent LC, Van Loo P, Møllgård K, Tommerup N, Bache I, Tümer Z, van Engelen K, Menten B, Mortier G, Waggoner D, Gewillig M, Moreau Y, Devriendt K, Larsen LA. Haploinsufficiency of TAB2 causes congenital heart defects in humans. Am J Hum Genet 86(6):839-49, 2010. e-Pub 2010. PMID: 20493459.
- Barriot R, Breckpot J, Thienpont B, Brohée S, Van Vooren S, Coessens B, Tranchevent LC, Van Loo P, Gewillig M, Devriendt K, Moreau Y. Collaboratively charting the gene-to-phenotype network of human congenital heart defects. Genome Med 2(3):16, 2010. e-Pub 2010. PMID: 20193066.
- Sagaert X, Tousseyn T, Vanhentenrijk V, Van Loo P, Baens M, Marynen P, De Hertogh G, Geboes K, De Wolf-Peeters C. Comparative expressed sequence hybridization studies of t(11;18)(q21;q21)-positive and -negative gastric MALT lymphomas reveal both unique and overlapping gene programs. Mod Pathol 23(3):458-69, 2010. e-Pub 2010. PMID: 20081812.
- Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. Haematologica 95(3):440-8, 2010. e-Pub 2010. PMID: 19797726.
- Sun W, Wright FA, Tang Z, Nordgard SH, Van Loo P, Yu T, Kristensen VN, Perou CM. Integrated study of copy number states and genotype calls using high-density SNP arrays. Nucleic Acids Res 37(16):5365-77, 2009. e-Pub 2009. PMID: 19581427.
- Lehnert S, Van Loo P, Thilakarathne PJ, Marynen P, Verbeke G, Schuit FC. Evidence for co-evolution between human microRNAs and Alu-repeats. PLoS One 4(2):e4456, 2009. e-Pub 2009. PMID: 19209240.
- Vanden Bempt I, Van Loo P, Drijkoningen M, Neven P, Smeets A, Christiaens MR, Paridaens R, De Wolf-Peeters C. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing. J Clin Oncol 26(30):4869-74, 2008. e-Pub 2008. PMID: 18794552.
- Tranchevent LC, Barriot R, Yu S, Van Vooren S, Van Loo P, Coessens B, De Moor B, Aerts S, Moreau Y. ENDEAVOUR update: a web resource for gene prioritization in multiple species. Nucleic Acids Res 36(Web Server issue):W377-84, 2008. e-Pub 2008. PMID: 18508807.
- Van Loo P, Aerts S, Thienpont B, De Moor B, Moreau Y, Marynen P. ModuleMiner - improved computational detection of cis-regulatory modules: are there different modes of gene regulation in embryonic development and adult tissues?. Genome Biol 9(4):R66, 2008. e-Pub 2008. PMID: 18394174.
- Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, Aerts S, Mahony S, Sleumer MC, Bilenky M, Haeussler M, Griffith M, Gallo SM, Giardine B, Hooghe B, Van Loo P, Blanco E, Ticoll A, Lithwick S, Portales-Casamar E, Donaldson IJ, Robertson G, Wadelius C, De Bleser P, Vlieghe D, Halfon MS, Wasserman W, Hardison R, Bergman CM, Jones SJ, The Open Regulatory Annotation Consortium. ORegAnno: an open-access community-driven resource for regulatory annotation. Nucleic Acids Res 36(Database issue):D107-13, 2008. e-Pub 2008. PMID: 18006570.
- Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P, Vermeesch J, Jarosova M, Zemanova Z, Michalova K, Van den Berghe I, Alexander HD, Hagemeijer A, Vandenberghe P, Cools J, De Wolf-Peeters C, Marynen P, Wlodarska I. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 21(9):2079-83, 2007. e-Pub 2007. PMID: 17525729.
- Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, Tranchevent LC, De Moor B, Marynen P, Hassan B, Carmeliet P, Moreau Y. Gene prioritization through genomic data fusion. Nat Biotechnol 24(5):537-44, 2006. e-Pub 2006. PMID: 16680138.
- Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, Moreau Y, De Moor B. TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 33(Web Server issue):W393-6, 2005. e-Pub 2005. PMID: 15980497.
- Aerts S, Van Loo P, Moreau Y, De Moor B. A genetic algorithm for the detection of new cis-regulatory modules in sets of coregulated genes. Bioinformatics 20(12):1974-6, 2004. e-Pub 2004. PMID: 15044242.
- Aerts S, Van Loo P, Thijs G, Moreau Y, De Moor B. Computational detection of cis-regulatory modules. Bioinformatics 19 Suppl 2:ii5-14, 2003. e-Pub 2003. PMID: 14534164.
Invited Articles
- Yan H, Tarabichi M, McGranahan N, Van Loo P. DeCiFering the subclonal composition of tumors. Cell Syst 12(10):955-957, 2021. e-Pub 2021. PMID: 34672959.
- Voet T, Van Loo P. SNES makes sense? Single-cell exome sequencing evolves. Genome Biol 16:86, 2015. e-Pub 2015. PMID: 25926122.
- Van Loo P, Campbell PJ. ABSOLUTE cancer genomics. Nat Biotechnol 30(7):620-1, 2012. e-Pub 2012. PMID: 22781683.
Review Articles
- Baker TM, Waise S, Tarabichi M, Van Loo P. Aneuploidy and complex genomic rearrangements in cancer evolution. Nat Cancer 5(2):228-239, 2024. e-Pub 2024. PMID: 38286829.
- Bowes AL, Tarabichi M, Pillay N, Van Loo P. Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers. J Pathol 257(4):466-478, 2022. e-Pub 2022. PMID: 35438189.
- Morotti M, Albukhari A, Alsaadi A, Artibani M, Brenton JD, Curbishley SM, Dong T, Dustin ML, Hu Z, McGranahan N, Miller ML, Santana-Gonzalez L, Seymour LW, Shi T, Van Loo P, Yau C, White H, Wietek N, Church DN, Wedge DC, Ahmed AA. Promises and challenges of adoptive T-cell therapies for solid tumours. Br J Cancer 124(11):1759-1776, 2021. e-Pub 2021. PMID: 33782566.
- Tarabichi M, Salcedo A, Deshwar AG, Ni Leathlobhair M, Wintersinger J, Wedge DC, Van Loo P, Morris QD, Boutros PC. A practical guide to cancer subclonal reconstruction from DNA sequencing. Nat Methods 18(2):144-155, 2021. e-Pub 2021. PMID: 33398189.
- Fittall MW, Van Loo P. Translating insights into tumor evolution to clinical practice: promises and challenges. Genome Med 11(1):20, 2019. e-Pub 2019. PMID: 30925887.
- Jolly C, Van Loo P. Timing somatic events in the evolution of cancer. Genome Biol 19(1):95, 2018. e-Pub 2018. PMID: 30041675.
- Macintyre G, Van Loo P, Corcoran NM, Wedge DC, Markowetz F, Hovens CM. How Subclonal Modeling Is Changing the Metastatic Paradigm. Clin Cancer Res 23(3):630-635, 2017. e-Pub 2017. PMID: 27864419.
- Van Loo P, Voet T. Single cell analysis of cancer genomes. Curr Opin Genet Dev 24:82-91, 2014. e-Pub 2014. PMID: 24531336.
- Van Loo P, Marynen P. Computational methods for the detection of cis-regulatory modules. Brief Bioinform 10(5):509-24, 2009. e-Pub 2009. PMID: 19498042.
Other Articles
- Frankell, AM, Dietzen, M, Al-Bakir, M, Lim, E, Karasaki, T, Ward, S, Veeriah, S, Colliver, E, Huebner, A, Bunkum, A, Hill, MS, Grigoriadis, K, Moore, DA, Black, JR, Liu, WK, Thol, K, Pich, O, Watkins, TB, Naceur-Lombardelli, C, Cook, DE, Salgado, R, Wilson, GA, Bailey, C, Angelova, M, Bentham, R, Martínez-Ruiz, C, Abbosh, C, Nicholson, A, Le Quesne, J, Biswas, D, Rosenthal, R, Puttick, C, Hessey, S, Lee, C, Prymas, P, Toncheva, A, Smith, JC, Xing, W, Nicod, J, Price, G, Kerr, K, Naidu, B, Middleton, G, Blyth, KG, Fennell, D, Forster, M, Lee, SM, Van Loo, P, Pan, X, Yuan, Y Author Correction. Nature 631(8022):E15, 2024. PMID: 38965439.
- Yakneen, S, Waszak, SM, Yakneen, S, Aminou, B, Bartolome, J, Boroevich, KA, Boyce, R, Brooks, AN, Buchanan, A, Buchhalter, I, Butler, A, Byrne, NJ, Cafferkey, A, Campbell, PJ, Chen, Z, Cho, S, Choi, W, Clapham, P, Davis-Dusenbery, BN, De La Vega, FM, Demeulemeester, J, Dow, MT, Dursi, LJ, Eils, J, Eils, R, Ellrott, K, Farcas, C, Favero, F, Fayzullaev, N, Ferretti, V, Flicek, P, Fonseca, NA, Gelpi, JL, Getz, G, Gibson, B, Grossman, RL, Harismendy, O, Heath, AP, Heinold, M, Hess, J, Hofmann, O, Hong, JH, Hudson, TJ, Hutter, B, Hutter, CM, Hübschmann, D, Imoto, S, Ivkovic, S, Jeon, SH, Van Loo, P Publisher Correction. Nature biotechnology 41(4):578, 2023. PMID: 32051562.
Book Chapters
- Dentro SC, Wedge DC, Van Loo P. Principles of Reconstructing the Subclonal Architecture of Cancers. In: Cancer Evolution. 8. Cold Spring Harbor Laboratory Press, 2017.
- Van Loo P, Nilsen G, Nordgard SH, Vollan HK, Børresen-Dale AL, Kristensen VN, Lingjærde OC. Analyzing cancer samples with SNP arrays. In: Microarray Bioinformatics, 57-72, 2012.
Letters to the Editor
- Megyesfalvi Z, Heeke S, Drapkin BJ, Solta A, Kovacs I, Boettiger K, Horvath L, Ernhofer B, Fillinger J, Renyi-Vamos F, Aigner C, Schelch K, Lang C, Marko-Varga G, Gay CM, Byers LA, Morris BB, Heymach JV, Van Loo P, Hirsch FR, Dome B. Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies. Cancer Cell 41: 1535-1540, 2023.
- Tarabichi M, Martincorena I, Gerstung M, Leroi AM, Markowetz F, Evolution P, Group HW, Spellman PT, Morris QD, Lingjærde OC, Wedge DC, Van Loo P. Neutral tumor evolution?. Nat Genet 50: 1630-1633, 2018.
Patient Reviews
CV information above last modified September 12, 2025